ARS Pharmaceuticals (SPRY) Long term liabilities

Annual long term liabilities:

$70.92M+$70.88M(+191562.16%)
December 31, 2024

Summary

  • As of today (June 30, 2025), SPRY annual total long term liabilities is $70.92 million, with the most recent change of +$70.88 million (+191562.16%) on December 31, 2024.
  • During the last 3 years, SPRY annual long term liabilities has fallen by -$13.61 million (-16.10%).
  • SPRY annual long term liabilities is now -16.10% below its all-time high of $84.53 million, reached on December 31, 2021.

Performance

SPRY Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

quarterly long term liabilities:

$70.72M-$193.00K(-0.27%)
March 31, 2025

Summary

  • As of today (June 30, 2025), SPRY quarterly total long term liabilities is $70.72 million, with the most recent change of -$193.00 thousand (-0.27%) on March 31, 2025.
  • Over the past year, SPRY quarterly long term liabilities has increased by +$70.72 million (+100.00%).
  • SPRY quarterly long term liabilities is now -16.33% below its all-time high of $84.53 million, reached on December 1, 2021.

Performance

SPRY quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

SPRY Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10000.0%+100.0%
3 y3 years-16.1%-
5 y5 years+119.9%-16.3%

SPRY Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-16.1%>+9999.0%-14.4%>+9999.0%
5 y5-year-16.1%>+9999.0%-16.3%>+9999.0%
alltimeall time-16.1%>+9999.0%-16.3%>+9999.0%

SPRY Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$70.72M(-0.3%)
Dec 2024
$70.92M(>+9900.0%)
$70.92M(>+9900.0%)
Sep 2024
-
$0.00(0.0%)
Jun 2024
-
$0.00(0.0%)
Mar 2024
-
$0.00(-100.0%)
Dec 2023
$37.00K
$37.00K(-59.8%)
Sep 2023
-
$92.00K(-37.0%)
DateAnnualQuarterly
Jun 2023
-
$146.00K(-26.6%)
Mar 2023
-
$199.00K(-93.6%)
Dec 2022
$3.10M(-96.3%)
$3.10M(-96.2%)
Jun 2022
-
$82.62M(-2.3%)
Dec 2021
$84.53M(+162.1%)
-
Dec 2021
-
$84.53M
Dec 2020
$32.25M
-

FAQ

  • What is ARS Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual long term liabilities for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual long term liabilities year-on-year change?
  • What is ARS Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly long term liabilities year-on-year change?

What is ARS Pharmaceuticals annual total long term liabilities?

The current annual long term liabilities of SPRY is $70.92M

What is the all time high annual long term liabilities for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual total long term liabilities is $84.53M

What is ARS Pharmaceuticals annual long term liabilities year-on-year change?

Over the past year, SPRY annual total long term liabilities has changed by +$70.88M (+191562.16%)

What is ARS Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of SPRY is $70.72M

What is the all time high quarterly long term liabilities for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly total long term liabilities is $84.53M

What is ARS Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, SPRY quarterly total long term liabilities has changed by +$70.72M (+100.00%)
On this page